Please provide your email address to receive an email when new articles are posted on . Clinical presentation of a 42-year-old man with acute onset of ocular discomfort and mild conjunctival infection ...

VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...

Please provide your email address to receive an email when new articles are posted on . Complications from the use of punctum plugs to treat aqueous insufficiency are fairly uncommon; however, adverse ...

BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical ...

VANCOUVER, British Columbia, Aug. 29, 2011 (GLOBE NEWSWIRE) -- QLT Inc. /quotes/zigman/13615/quotes/nls/qlti QLTI +1.81% /quotes/zigman/13629 CA:QLT +1.99% today ...

If you have dry eyes and your symptoms don’t improve with artificial tears, a doctor may recommend punctal plugs. They can help reduce excess tear loss from the ducts in your eyes. Share on Pinterest ...

Punctal plugs (PP) insertion is an effective and reversible method to treat dry eye syndrome (DES) and some other ocular surface diseases. Non-absorbable plugs made of silicon are the most commonly ...

We investigated the efficacy of lacrimal punctal occlusion surgery with a cautery device in patients with chronic GVHD (cGVHD)-related dry eye, with recanalization of puncta and recurrent punctal plug ...

QLT Inc. announced results of its phase II clinical study on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (LPPDS) in subjects with Ocular Hypertension (OH) and Open-Angle ...

Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost ...